A Research on the Risk of Intervention in Antipyretics for Children

Abstract

Abstract: This paper describes the varieties, usage situations and adverse reactions of Antipyretics for children and analyses the sources of risk of the drugs for children. The registration schemes and interventions in the adverse reactions of drugs for children in USA and Europe have been concluded by scanning the official websites of FDA and EMEA. At the end of the paper, the advice related with the risk of antipyretic for children are brought up to contribute to safe use of antipyretics for children in China.

Key words: antipyretics for children, sources of risk, intervention

ZHANG Hao, ZHAO Pin, WU Zhi-ang. A Research on the Risk of Intervention in Antipyretics for Children[J]. Chinese Journal of Pharmacovigilance, 2012, 9(4): 218-221.

Add to citation manager EndNote|Ris|BibTeX

URL: https://zgywjj.magtechjournal.com/EN/

https://zgywjj.magtechjournal.com/EN/Y2012/V9/I4/218

[1]	WANG Yuan, LI Ruoning, GUO Zhanli, ZHANG Lei, LI Jiayuan, DONG Ying, SUN Jianjun. One Case of Extremely Severe Thrombocytopenia Caused by Tirofiban Injection [J]. Chinese Journal of Pharmacovigilance, 2025, 22(7): 815-818.
[2]	QIU Jinghui, ZHOU Huziwei, CAO Ying, LI Wenpeng, WANG Shengfeng. Research progress on the influencing factors and intervention measures of opioid requirements [J]. Chinese Journal of Pharmacovigilance, 2024, 21(5): 524-528.
[3]	FAN Kaikai, WANG Cong, LIU Hongfeng, WANG Xiyong. Effects of clinical pharmacist interventions on usage of alanyl-glutamine injections in a hospital [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 181-184.
[4]	NIE Xiaolu, TANG Shaowen, YU Jinyang, SONG Haibo, FU Zhu, SUN Feng. Interpretations of reporting recommendations intended for pharmaceutical risk minimization evaluation studies(RIMES) statement [J]. Chinese Journal of Pharmacovigilance, 2023, 20(5): 524-529.
[5]	YIN Jinjun, WANG Shuwei, SHAO Jiangchao, WANG Bing. Drug use evaluation of bevacizumab injection based on weighted TOPSIS method [J]. Chinese Journal of Pharmacovigilance, 2023, 20(12): 1421-1426.
[6]	XIANG Yunxia, PU Wen, LI Dongfeng, WANG Jie. Effects of pharmacists' intervention on anticoagulant management of patients treated with warfarin after heart valve replacement [J]. Chinese Journal of Pharmacovigilance, 2022, 19(5): 545-549.
[7]	ZHU Yulei, LI Xin. Current Policies and Evaluation of Antimicrobial Management [J]. Chinese Journal of Pharmacovigilance, 2021, 18(9): 855-859.
[8]	WAN Kaihua, WEI Yu, XU Yuming, ZHOU Juan. Current Status of Drug Abuse Epidemic and Intervention Research in China [J]. Chinese Journal of Pharmacovigilance, 2019, 16(6): 338-341.
[9]	GUO Xiaoli. Application of Bivaludine Combined with Tirofiban in Patients with STEMI without Reflow or Slow Blood Flow during Coronary Intervention [J]. Chinese Journal of Pharmacovigilance, 2019, 16(5): 260-264.
[10]	WANG Minglei, WANG Fang. Effects of Out-hospital Extended Pharmaceutical Intervention in Myocardial Infarction Patients after PCI on Prognosis and Medication Compliance [J]. Chinese Journal of Pharmacovigilance, 2018, 15(8): 485-488.
[11]	LI Zhi-cheng. Pharmaceutical Care on One Case of Gastrointestinal Hemorrhage Caused by Anticoagulant Drugs in a Patient with Percutaneous Coronary Intervention Combined with Pulmonary Embolism [J]. Chinese Journal of Pharmacovigilance, 2018, 15(5): 308-311.
[12]	YANG Chenchen, ZHAO Yinglian, LIU Kai. Analysis of Unreasonable Prescription Intervention of A Mental Hospital Outpatient Pharmacy from 2016 to 2017 [J]. Chinese Journal of Pharmacovigilance, 2018, 15(12): 751-754.
[13]	ZHOU Li, LI Er-ping, WEI Jing-tu, BAN Bing-kun. Investigation of Cognition on Drug Safety Knowledge and Drug Use Behavior and Intervention Research of Middle School Students in Remote Minority Areas [J]. Chinese Journal of Pharmacovigilance, 2017, 14(6): 372-374.
[14]	LIU Xue-wu, ZHANG Xia-zhi, ZHANG Fang-lan. Effect of Oral Tongxinluo Capsule on Endothelial Microparticles and Matrix Metalloproteinase-9 in Serum of Patients with Acute Myocardial Infarction after Percutaneous Coronary Intervention [J]. Chinese Journal of Pharmacovigilance, 2017, 14(3): 142-144.
[15]	GUO Hua, WANG Tong, SUN Xiao-mei. Effects of Tirofiban Intracoronary Administration on the Interventional Therapy and Peripheral Blood PMPs Level in Patients with Acute ST-segment Elevation Myocardial Infarction [J]. Chinese Journal of Pharmacovigilance, 2017, 14(3): 145-149.

A Research on the Risk of Intervention in Antipyretics for Children

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics